Early Versus Late Initiation of Evolocumab and Arterial Aneurysm Events: An Analysis of FOURIER and FOURIER-OLE

A Andre Zimerman (TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston) P Prakriti Gaba (Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA (P.G., M.L.O., R.P.G., M.S.S., N.A.M., B.A.B.).) M Michelle L. O’Donoghue (TIMI (Thrombolysis in Myocardial Infarction Study) Group, Boston, MA (V.M., N.A.M., E.A.B., J.-G.P., J.F.K., S.A.M., R.P.G., M.S.S., M.L.O.).) R Robert P. Giugliano S Sabina A. Murphy (TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston) X Xinhui Ran (Thrombolysis in Myocardial Infarction Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston, MA (N.A.M., B.A.B., X.R., S.A.M., S.Z., R.P.G., M.S.S.).) J Julia F. Kuder (Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston) R Richard Ceska (Center of Preventive Cardiology, Third Department of Internal Medicine, University General Hospital, Prague, Czech Republic (R.C.).) G Gaetano M. De Ferrari (Cardiology Division, Department of Medical Sciences, University of Turin and Azienda Ospedaliero–Universitaria Città della Salute e della Scienza, Turin, Italy) J Jorge Ferreira (Department of Cardiology, Santa Cruz Hospital, Western Lisbon Local Health Unit, Portugal (J.F.).) Z Zbigniew A. Gaciong (Department of Internal Medicine, Hypertension and Vascular Diseases, Medical University of Warsaw, Poland (Z.A.G.).) J Jose Lopez-Sendon (IdiPaz Research Institute, Hospital Universitario La Paz, Universidad Autonoma de Madrid, Spain (J.L.-S.).) A Alberto Lorenzatti (DAMIC Medical Institute, Rusculleda Foundation for Research, Cordoba, Argentina (A.L.).) J José F.K. Saraiva (Faculdade de Medicina da Pontifícia Universidade Católica de Campinas, Brazil (J.F.K.S.).) J J. Wouter Jukema (Department of Cardiology, Leiden University Medical Center, The Netherlands (J.W.J.).) M Maria-Laura Monsalvo (Global Development, Amgen, Inc., Thousand Oaks, CA (M.-L.M.).) J Jose H. Flores-Arredondo (Center for Design and Analysis, Amgen, Thousand Oaks, CA (J.H.F.-A.).) D Dan Atar (Department of Cardiology, Oslo University Hospital Ullevaal, Oslo) A Anthony C. Keech (Department of Medicine, University of Sydney and Royal Prince Alfred Hospital, Australia (A.C.K.).) M Marc S. Sabatine (TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston) N Nicholas A. Marston (TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston) B Brian A. Bergmark (TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston)

Article Details

Journal Circulation
Volume / Issue Vol. 153, Issue 19
Published May 12, 2026
Pages 1516-1519
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (22)

A

Andre Zimerman

TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston

P

Prakriti Gaba

Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA (P.G., M.L.O., R.P.G., M.S.S., N.A.M., B.A.B.).

M

Michelle L. O’Donoghue

TIMI (Thrombolysis in Myocardial Infarction Study) Group, Boston, MA (V.M., N.A.M., E.A.B., J.-G.P., J.F.K., S.A.M., R.P.G., M.S.S., M.L.O.).

R

Robert P. Giugliano

S

Sabina A. Murphy

TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston

X

Xinhui Ran

Thrombolysis in Myocardial Infarction Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston, MA (N.A.M., B.A.B., X.R., S.A.M., S.Z., R.P.G., M.S.S.).

J

Julia F. Kuder

Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston

R

Richard Ceska

Center of Preventive Cardiology, Third Department of Internal Medicine, University General Hospital, Prague, Czech Republic (R.C.).

G

Gaetano M. De Ferrari

Cardiology Division, Department of Medical Sciences, University of Turin and Azienda Ospedaliero–Universitaria Città della Salute e della Scienza, Turin, Italy

J

Jorge Ferreira

Department of Cardiology, Santa Cruz Hospital, Western Lisbon Local Health Unit, Portugal (J.F.).

Z

Zbigniew A. Gaciong

Department of Internal Medicine, Hypertension and Vascular Diseases, Medical University of Warsaw, Poland (Z.A.G.).

J

Jose Lopez-Sendon

IdiPaz Research Institute, Hospital Universitario La Paz, Universidad Autonoma de Madrid, Spain (J.L.-S.).

A

Alberto Lorenzatti

DAMIC Medical Institute, Rusculleda Foundation for Research, Cordoba, Argentina (A.L.).

J

José F.K. Saraiva

Faculdade de Medicina da Pontifícia Universidade Católica de Campinas, Brazil (J.F.K.S.).

J

J. Wouter Jukema

Department of Cardiology, Leiden University Medical Center, The Netherlands (J.W.J.).

M

Maria-Laura Monsalvo

Global Development, Amgen, Inc., Thousand Oaks, CA (M.-L.M.).

J

Jose H. Flores-Arredondo

Center for Design and Analysis, Amgen, Thousand Oaks, CA (J.H.F.-A.).

D

Dan Atar

Department of Cardiology, Oslo University Hospital Ullevaal, Oslo

A

Anthony C. Keech

Department of Medicine, University of Sydney and Royal Prince Alfred Hospital, Australia (A.C.K.).

M

Marc S. Sabatine

TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston

N

Nicholas A. Marston

TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston

B

Brian A. Bergmark

TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston